Serum TWEAK in acne vulgaris: An unknown soldier (original) (raw)
Changes in serum TNF‐like weak inducer of apoptosis (TWEAK) levels and Psoriasis Area Severity Index (PASI) scores in plaque psoriasis patients treated with conventional versus anti‐TNF treatments
Zekayi Kutlubay
International Journal of Dermatology, 2019
View PDFchevron_right
TWEAK Affects Keratinocyte G2/M Growth Arrest and Induces Apoptosis through the Translocation of the AIF Protein to the Nucleus
Efstathios Stathopoulos
PLoS ONE, 2012
View PDFchevron_right
Expression of TWEAK in normal human skin, dermatitis and epidermal neoplasms: association with proliferation and differentiation of keratinocytes
Ines Brajac
Journal of Cutaneous Pathology, 2011
View PDFchevron_right
TNF-Like Weak Inducer of Apoptosis (TWEAK) Activates Proinflammatory Signaling Pathways and Gene Expression through the Activation of TGF- -Activated Kinase 1
ashok kumar g ashok kumar g
The Journal of Immunology, 2009
View PDFchevron_right
Dithranol treatment of plaque-type psoriasis increases serum TNF-like weak inducer of apoptosis (TWEAK)
Hanna Myśliwiec
Advances in Medical Sciences, 2016
View PDFchevron_right
A pilot study on serum cutaneous T-cell-attracting chemokine in acne patients
Enas Attia
Journal of the Egyptian Women's Dermatologic Society (Print), 2014
View PDFchevron_right
Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies
Jeff Thompson
Arthritis research, 2002
View PDFchevron_right
Survivin as a Novel Biomarker in the Pathogenesis of Acne Vulgaris and Its Correlation to Insulin-Like Growth Factor-I
Mohamed Adly
Disease Markers, 2016
View PDFchevron_right
Effects of Tumor Necrosis Factor-α (TNFα) in Epidermal Keratinocytes Revealed Using Global Transcriptional Profiling
Miroslav Blumenberg
Journal of Biological Chemistry, 2004
View PDFchevron_right
Inhibition of Keratinocyte Apoptosis by IL-15: A New Parameter in the Pathogenesis of Psoriasis?
Khusru Asadullah
The Journal of Immunology, 2000
View PDFchevron_right
Levels of IL-12, IL-17, and LL-37 in Acne Vulgaris
harmita aprilanti
Turkish Journal of Immunology, 2018
View PDFchevron_right
4-Clinical and Experimental Dermatology.pdf
Javeria Haroon
View PDFchevron_right
Tumor necrosis factor-α −308 G/A and interleukin 10 −1082 A/G gene polymorphisms in patients with acne vulgaris
Ahmad Settin
Journal of Dermatological Science, 2012
View PDFchevron_right
Interleukin-35 Level in Acne Vulgaris
hassan mohamed
The Egyptian Journal of Hospital Medicine, 2021
View PDFchevron_right
Serum TWEAK: A cutoff between segmental and nonsegmental vitiligo
Rehab Salem
Journal of Cosmetic Dermatology, 2020
View PDFchevron_right
Impaired PI3K/Akt Activation-Mediated NF-κB Inactivation Under Elevated TNF-α Is More Vulnerable to Apoptosis in Vitiliginous Keratinocytes
Songhee Jeon
Journal of Investigative Dermatology, 2007
View PDFchevron_right
Pathophysiology of acne
Claudia Borelli
JDDG, 2007
View PDFchevron_right
Toll-like Receptor 2 and P-acnes: Do They Trigger Initial Acne Vulgaris Lesions?
ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY
ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY, 2014
View PDFchevron_right
New developments in our understanding of acne pathogenesis and treatment
Fragkiski Tsatsou
Experimental Dermatology, 2009
View PDFchevron_right
Evaluation of Serum Survivin level in Patients with Acne Vulgaris
hanan samy
Benha Medical Journal
View PDFchevron_right
The Expression of BAFF, APRIL and TWEAK Is Altered in Eczema Skin but Not in the Circulation of Atopic and Seborrheic Eczema Patients
Gunnar Nilsson
PLoS ONE, 2011
View PDFchevron_right
Current Concepts in Acne Pathogenesis: Pathways to Inflammation
Jerry Tan
Seminars in cutaneous medicine and surgery, 2018
View PDFchevron_right
The Immunogenetic Analysis of Acne Vulgaris
Irawan Yusuf
Science Journal of Clinical Medicine, 2013
View PDFchevron_right
Assessment of Tumor necrosis factor alpha gene polymorphisms (-857and -863) In Acne Vulgaris Patients and their Correlation with Disease Severity
Manal Mohamed
The Egyptian Journal of Hospital Medicine, 2024
View PDFchevron_right
Serum interleukin‐17 as a novel biomarker in patients with acne vulgaris
Awad Elabd
Journal of Cosmetic Dermatology, 2019
View PDFchevron_right
TWEAK can induce cell death via endogenous TNF and TNF receptor 1
Pascal Schneider
European Journal of Immunology, 1999
View PDFchevron_right
Recent advances in acne vulgaris research: insights and clinical implications
Kevin Wang
Advances in dermatology, 2008
View PDFchevron_right
Expression of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor, fibroblast growth factor-inducible 14 protein (Fn14), in healthy tissues and in tissues affected by periodontitis
David Haynes
Journal of Periodontal Research, 2010
View PDFchevron_right
Inflammation in acne scarring: a comparison of the responses in lesions from patients prone and not prone to scar
Alison Layton
British Journal of Dermatology, 2004
View PDFchevron_right
Impact of TNF Haplotypes in the Physical Course of Acne Vulgaris
Sophia Giatrakou
Dermatology, 2013
View PDFchevron_right
The role of neuropeptides in the multifactorial pathogenesis of acne vulgaris
ruta ganceviciene
Dermato-endocrinology, 2009
View PDFchevron_right
TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumour necrosis factor blockade
Paul Tak
Annals of the Rheumatic Diseases, 2010
View PDFchevron_right
TNF-α and IFN-γ Are Potential Inducers of Fas-Mediated Keratinocyte Apoptosis through Activation of Inducible Nitric Oxide Synthase in Toxic Epidermal Necrolysis
Peter Friedmann
Journal of Investigative Dermatology, 2013
View PDFchevron_right
Lesional and circulating levels of interleukin-17 and 25-hydroxycholecalciferol in active acne vulgaris: Correlation to disease severity
Essam Nada
Journal of cosmetic dermatology, 2018
View PDFchevron_right